# South Korea Ventricular Assist Devices Market

> South Korea Ventricular Assist Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device), By Types of Flow (Continuous Flow, Pulsatile Flow), By Design (Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device) and By Applications (Destination Therapy, Bridging Therapy) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 8.22%
- **2024:** $ 39 Million
- **2025:** $ 42.21 Million
- **2035:** $ 93 Million
- **Key Players:** Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), Cleveland Heart (US), ReliantHeart (US), Syncardia (US), Getinge (SE), CardiacAssist (US)

**Report ID:** MRFR/HC/49687-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-ventricular-assist-devices-market-51445

---

## Market Summary

## **South Korea Ventricular Assist Devices Market Overview**

As per MRFR analysis, the South Korea Ventricular Assist Devices Market Size was estimated at 36 (USD Million) in 2023. The South Korea Ventricular Assist Devices Market Industry is expected to grow from 39(USD Million) in 2024 to 87 (USD Million) by 2035. The South Korea Ventricular Assist Devices Market CAGR (growth rate) is expected to be around 7.567% during the forecast period (2025 - 2035).

**Key South Korea Ventricular Assist Devices Market Trends Highlighted**

In South Korea, the Ventricular Assist Devices (VAD) market is witnessing significant trends driven by a heightened focus on cardiovascular health due to increasing cases of heart failure. The aging population, which is a critical demographic in South Korea, exhibits a rising prevalence of heart-related diseases, thereby increasing the demand for VADs as a solution. Government initiatives aimed at enhancing healthcare infrastructure and supporting advanced cardiac care play a vital role in promoting the adoption of VAD technology.

Advanced manufacturing and innovative technology in South Korean medical device companies have led to improvements in device performance, which is another key driver of market growth.There are local businesses and international companies that can work together to improve the research and development of VADs that are more efficient and easier for patients. Also, the development of these devices can lead to a greater market through instructional programs and supporting frameworks for healthcare professionals on the right application of these devices.

The government in South Korea has made steps towards bolstering its funding for developing medical technology, which strengthens the possibilities for a higher market. There is a current market shift to smaller portable devices that allow patients to better manage their daily activities, which is along the wider scope of the healthcare industry’s focus on a more patient-oriented healthcare system.

The rising acceptance of VADs in clinical practices indicates a deeper understanding and evolution in cardiac care protocols. Consequently, this environment fosters innovation and sets the stage for further advancements in technology tailored to South Korean patients’ needs, making the VAD market a dynamic and promising sector in the regional healthcare landscape.

Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review**

**South Korea Ventricular Assist Devices Market Drivers**

**Increasing Prevalence of Heart Diseases**

The rise in heart disease cases in South Korea is a significant driver of the South Korea Ventricular Assist Devices Market. According to the National Health Insurance Service of South Korea, cardiovascular diseases accounted for approximately 30% of total deaths in 2020, highlighting a dire need for advanced medical devices such as ventricular assist devices. Furthermore, the Korean Society of Cardiology has reported a steep increase in heart failure cases, increasing by over 15% from 2015 to 2020.

This surge in cardiovascular-related health issues is prompting hospitals and healthcare providers to invest in innovative therapies, including ventricular assist devices, to improve patient outcomes. Major organizations within the region, like Samsung Medical Center and Asan Medical Center, are leading the charge in adopting these devices, thereby enhancing market growth prospects in this sector.

**Technological Advancements in Medical Devices**

The South Korea Ventricular Assist Devices Market Industry is significantly influenced by continuous technological advancements in medical devices. Innovations such as the development of smaller, more efficient, and more durable devices are gaining traction. Reports indicate that between 2020 and 2025, the demand for next-generation ventricular assist devices, which can improve the quality of life for patients and allow for greater mobility, has been surging.Organizations like LG Electronics have invested in Research and Development (R&D) to create sophisticated monitoring technologies for these devices, positively impacting patient safety and operational efficiency.

This trend is expected to facilitate a more favorable regulatory environment as well, pushing market growth as these innovative solutions become available.

**Growing Geriatric Population**

The aging population in South Korea presents a significant driver for the South Korea Ventricular Assist Devices Market. Currently, the proportion of individuals aged 65 and older is projected to exceed 20% by 2025, according to Statistics Korea. Older adults are more prone to cardiovascular diseases, which increases the demand for ventricular assist devices.

The Korean Ministry of Health and Welfare has identified heart disease as a leading health concern among the elderly, further solidifying the need for advanced medical care solutions.Hospitals in South Korea, including Seoul National University Hospital, are already evolving their care protocols to include ventricular assist devices as a standard treatment option for elderly patients with severe heart conditions.

**Increased Funding for Healthcare Infrastructure**

In South Korea, the government is progressively increasing funding for healthcare infrastructure, benefiting the South Korea Ventricular Assist Devices Market Industry. Changes in public policy, such as increased health expenditure as specified in the South Korean government's 'Health and Welfare Reform Plan', aim to boost the quality of medical services and technologies.

A budget increase of nearly 10% for healthcare was confirmed for the fiscal year 2021, reflecting a commitment to improving health outcomes through advanced technologies, including ventricular assist devices.This upward trend in healthcare investments supports further growth opportunities for manufacturers and healthcare providers engaging in the ventricular assist devices sector, ensuring they have access to necessary resources for development and implementation.

**South Korea Ventricular Assist Devices Market Segment Insights**

**Ventricular Assist Devices Market Product Type Insights**

The South Korea Ventricular Assist Devices Market exhibits a diverse landscape segmented by Product Type, which primarily includes Left Ventricular Assist Devices, Right Ventricular Assist Devices, and Biventricular Assist Devices. Among these, Left Ventricular Assist Devices tend to dominate the market due to their critical role in aiding patients with advanced heart failure, which is a prevalent condition in South Korea. The increasing incidence of coronary artery disease and the aging population contribute significantly to the growing demand for these devices.

Right Ventricular Assist Devices also play an essential role, particularly in patients undergoing heart transplantation or those who have unique hemodynamic needs that require specific support. The awareness of heart failure and the necessity for advanced therapeutic options have spurred the development and adoption of such devices within the region. Biventricular Assist Devices, while less common, represent a vital solution for patients exhibiting failure in both ventricles, showcasing the market's focus on comprehensive care for complex cardiac conditions. Technological advancements in device design and increased focus on patient-centered outcomes continue to drive innovations in the field.

Moreover, partnerships between medical device manufacturers and hospitals in South Korea aim at improving patient access to these critical technologies, thus propelling the South Korea Ventricular Assist Devices Market forward. The supportive regulatory environment and initiatives aimed at enhancing healthcare accessibility also present opportunities for greater market penetration. As healthcare systems evolve and incorporate cutting-edge treatments, the frequency of usage of these devices is expected to grow. Furthermore, various health programs targeting chronic conditions highlight the importance of specialized heart care, emphasizing the need for Left, Right, and Biventricular Assist Devices in effective patient management and improved quality of life.

The South Korea Ventricular Assist Devices Market segmentation showcases a robust framework expected to evolve continually in response to emerging trends and patient needs in the cardiovascular domain.

Source: Primary Research, Secondary Research, _Market Research Future_ Database**,****and Analyst Review**

**Ventricular Assist Devices Market Type of Flow Insights**

The South Korea Ventricular Assist Devices Market includes a crucial segmentation by Type of Flow, primarily consisting of Continuous Flow and Pulsatile Flow devices. Continuous Flow devices have gained substantial traction due to their efficiency in providing a steady blood supply and their reduced mechanical complexity, making them more reliable for patient use.

This segment holds a significant advantage in both outpatient settings and during long-term bridge-to-transplant scenarios, allowing patients greater mobility and an improved quality of life.Conversely, Pulsatile Flow devices, while traditionally used, are being re-evaluated due to advancements in Continuous Flow technology; they still hold importance in specific cases, such as in pediatric patients or others requiring more interactive cardiac assistance. The dynamics within the South Korea Ventricular Assist Devices Market reflect a growing trend towards innovative solutions that cater to the escalating patient needs, with continuous performance improvement driving a shift towards Continuous Flow options.

As the healthcare system in South Korea continues investing in advanced cardiac technologies, both device types are likely to coexist, serving different patient requirements and scenarios.This nuanced segmentation highlights the varied approaches in the region's strategy to manage heart failure more effectively.

**Ventricular Assist Devices Market Design Insights**

The South Korea Ventricular Assist Devices Market is evolving with a focus on the Design aspect, reflecting significant innovation and development in the field. In particular, the Implantable Ventricular Assist Device segment holds a prominent position, being crucial for patients suffering from severe heart failure, as it provides long-term support and effectively improves their quality of life.

Meanwhile, the Transcutaneous Ventricular Assist Device segment has also been gaining attention due to its potential for non-invasive use, thus enhancing patient comfort and accessibility to treatment options.The growing geriatric population in South Korea and the increasing prevalence of heart-related ailments are primary growth drivers for these segments. Moreover, advancements in technology and design have paved the way for these devices to become more efficient and patient-friendly, contributing to their rising adoption rates. Nevertheless, challenges such as high manufacturing costs and regulatory hurdles may impact market dynamics.

Overall, the emphasis on advanced design elements and functionality in both segments plays a critical role in the market growth by addressing the increasing demands for effective heart failure management solutions in South Korea.

**Ventricular Assist Devices Market Application Insights**

The South Korea Ventricular Assist Devices Market, primarily categorized by Application, shows robust potential for expansion as it addresses critical cardiac support needs within the healthcare system. The major categories in this segment include Destination Therapy and Bridging Therapy, both serving significant roles in patient management. Destination Therapy is essential for those patients with advanced heart failure who are not candidates for heart transplantation, offering a long-term solution that improves morbidity and quality of life. Conversely, Bridging Therapy aims to temporarily support patients awaiting heart transplants, highlighting its importance in urgent care scenarios.

The increasing incidence of heart-related disorders in South Korea, driven by an aging population and lifestyle-related factors, contributes significantly to the demand for these therapies. Additionally, advancements in technology and increasing investments in Research and Development are likely to enhance the efficiency and outcomes of these devices, ensuring that they meet the evolving needs of the population. Addressing both therapeutic approaches within the broader South Korea Ventricular Assist Devices Market framework presents a compelling opportunity for stakeholders aiming to improve patient outcomes in the cardiac healthcare landscape.

**South Korea Ventricular Assist Devices Market Key Players and Competitive Insights**

The South Korea Ventricular Assist Devices Market has shown compelling dynamics and a robust competitive landscape, influenced by the rising prevalence of cardiovascular diseases and an aging population. This market is characterized by various key players striving to innovate and improve their product offerings, aiming to enhance patient outcomes. Driven by advancements in technology and a focus on research and development, companies are increasingly investing in the introduction of next-generation ventricular assist devices with improved features and functionalities.

Moreover, the market's competitive insights reveal a vibrant environment where companies are not only competing on product efficacy and safety but also on pricing, distribution channels, and specialized services that can provide comprehensive solutions for patients with heart failure.Getinge has established a significant presence in the South Korea Ventricular Assist Devices Market, leveraging its extensive experience and expertise in the medical technology field. The company's strengths in this region are evident through its innovative approach and commitment to improving patient care. Getinge's product range includes advanced ventricular assist devices designed to support patients with severe heart conditions.

The company is well-regarded for its dependable customer service and strong distribution network, which allows for effective delivery and support of its products across South Korea. Additionally, Getinge's continuous investments in research and development foster a culture of innovation, ensuring that it remains a formidable competitor in the market.SynCardia holds a notable position in the South Korea Ventricular Assist Devices Market, primarily known for its pioneering efforts in mechanical circulatory support. The company specializes in the production of total artificial hearts and ventricular assist devices, aimed at providing durable solutions for patients awaiting heart transplants.

SynCardia's strengths lie in its advanced technology and successful clinical outcomes, which have been beneficial in establishing its credibility in the South Korean healthcare landscape. The company emphasizes partnerships and collaborations to enhance its footprint and expand its services within the region. Furthermore, SynCardia has made strategic moves, including mergers and acquisitions, to bolster its market presence and leverage new capabilities that enhance its product offerings. Its commitment to innovation, coupled with a strong focus on patient-centric solutions, reinforces its competitive edge in the South Korean market.

**Key Companies in the South Korea Ventricular Assist Devices Market Include**

- Getinge
- SynCardia
- Cleveland Heart
- Thoratec
- Tandem Diabetes Care
- CardiacAssist
- Jiangsu Jichun Medical
- Berlin Heart
- Medtronic
- Acelity
- Abiomed
- LivaNova
- Terumo
- Sorin Group
- Abbott

**South Korea Ventricular Assist Devices Market Industry Developments**

The South Korea Ventricular Assist Devices Market has witnessed significant recent developments, particularly in technology advancements and market expansion. In September 2023, Getinge announced the launch of its latest heart pump technology in South Korea, enhancing treatment options for patients with severe heart conditions. SynCardia, in collaboration with local hospitals, has been increasing the adoption of portable total artificial hearts, which received updated regulatory approval earlier this year.

Additionally, Thoratec's strategic partnerships with South Korea-based research institutions have focused on improving device integration, benefiting patient outcomes.Current affairs reveal that Medtronic plans to increase its footprint in the South Korean market, which is projected to grow due to an increasing aging population and rising cardiology-related health issues. The market valuation for companies like Abiomed and LivaNova has also seen a positive increase due to burgeoning demand for heart failure therapies. Notably, in March 2023, Berlin Heart completed a successful acquisition of a South Korean-based cardiac technology firm to expand its product offerings, evidencing ongoing consolidation in the sector.

The overall market growth illustrates a robust response to the growing healthcare needs within South Korea's cardiovascular landscape.

**South Korea Ventricular Assist Devices Market Segmentation Insights**

**Ventricular Assist Devices Market Product Type****Outlook**

- Left Ventricular Assist Device
- Right Ventricular Assist Device
- Biventricular Assist Device

**Ventricular Assist Devices Market Type of Flow****Outlook**

- Continuous Flow
- Pulsatile Flow

**Ventricular Assist Devices Market Design****Outlook**

- Implantable Ventricular Assist Device
- Transcutaneous Ventricular Assist Device

**Ventricular Assist Devices Market Application****Outlook**

- Destination Therapy
- Bridging Therapy

## Market Drivers

### Advancements in Medical Technology

Technological innovations in the field of medical devices are significantly influencing the ventricular assist-devices market. Recent developments have led to the creation of smaller, more efficient, and biocompatible devices that enhance patient comfort and outcomes. For instance, the introduction of continuous-flow devices has revolutionized treatment options, allowing for longer-lasting support with reduced complications. The South Korean market is witnessing a shift towards these advanced technologies, which are not only improving the quality of life for patients but also expanding the potential applications of ventricular assist devices. As healthcare systems increasingly adopt these innovations, the market is expected to experience substantial growth. The ongoing research and development efforts in this sector indicate a promising future for the ventricular assist-devices market, as manufacturers strive to deliver cutting-edge solutions that address the evolving needs of patients and healthcare providers.

### Increasing Incidence of Heart Failure

The rising prevalence of heart failure in South Korea is a critical driver for the ventricular assist-devices market. According to recent health statistics, heart failure cases have surged, with estimates indicating that approximately 1 in 5 adults over the age of 65 may develop this condition. This alarming trend necessitates advanced treatment options, including ventricular assist devices, to manage severe heart failure effectively. The growing patient population requiring mechanical circulatory support is likely to propel the demand for these devices. Furthermore, as healthcare providers seek to improve patient outcomes, the integration of ventricular assist devices into treatment protocols appears increasingly essential. This trend suggests a robust market potential for manufacturers and suppliers within the ventricular assist-devices market, as they strive to meet the needs of a growing demographic facing heart-related challenges.

### Aging Population and Healthcare Demand

The demographic shift towards an aging population in South Korea is a significant driver for the ventricular assist-devices market. With a growing number of elderly individuals, the demand for advanced cardiac care is likely to increase. Statistics reveal that by 2030, nearly 20% of the South Korean population will be aged 65 and older, a demographic that is particularly susceptible to heart diseases. This trend underscores the necessity for effective treatment options, including ventricular assist devices, to manage age-related cardiac conditions. As healthcare providers adapt to the needs of this aging population, the market for ventricular assist devices is expected to expand. The increasing focus on improving the quality of life for elderly patients further emphasizes the importance of these devices in contemporary healthcare strategies, suggesting a robust market outlook for the ventricular assist-devices market.

### Rising Investment in Healthcare Infrastructure

The South Korean government's commitment to enhancing healthcare infrastructure is a pivotal factor driving the ventricular assist-devices market. Recent initiatives aimed at improving hospital facilities and expanding access to advanced medical technologies are likely to facilitate the adoption of ventricular assist devices. Increased funding for healthcare projects, including the establishment of specialized cardiac care centers, is expected to create a conducive environment for the growth of the market. Furthermore, as hospitals upgrade their capabilities to provide comprehensive cardiac care, the demand for innovative devices is anticipated to rise. This investment in healthcare infrastructure not only supports the availability of ventricular assist devices but also fosters an ecosystem that encourages research and development in this field. Consequently, the ventricular assist-devices market is poised for growth as healthcare systems evolve to meet the needs of patients requiring advanced cardiac support.

### Enhanced Training and Education for Healthcare Professionals

The emphasis on training and education for healthcare professionals in South Korea is emerging as a crucial driver for the ventricular assist-devices market. As the complexity of managing patients with heart failure increases, the need for specialized knowledge in the use of ventricular assist devices becomes paramount. Initiatives aimed at providing comprehensive training programs for medical staff are likely to improve the understanding and application of these devices in clinical settings. Enhanced education not only equips healthcare providers with the necessary skills but also fosters confidence in utilizing advanced technologies. This, in turn, may lead to increased adoption rates of ventricular assist devices, as practitioners become more adept at integrating them into treatment protocols. The focus on professional development within the healthcare sector suggests a positive trajectory for the ventricular assist-devices market, as well-trained personnel are essential for optimizing patient outcomes.

## Future Outlook

The [Ventricular Assist Devices Market](https://www.marketresearchfuture.com/reports/ventricular-assist-devices-market-9777) is projected to grow at an 8.22% CAGR from 2025 to 2035, driven by technological advancements, increasing heart failure prevalence, and rising healthcare investments.

**New opportunities:**

- Development of portable ventricular assist devices for home care settings.
- Partnerships with hospitals for integrated patient management solutions.
- Expansion into emerging markets with tailored financing options.

By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic partnerships.

## Segment Insights

### By Product Type: LVAD (Largest) vs. RVAD (Fastest-Growing)

In the South Korea ventricular assist-devices market, the dominant segment is the Left Ventricular Assist Device (LVAD), capturing a significant portion of the market share. This device is primarily utilized for patients suffering from severe heart failure, making it a go-to solution for healthcare providers. Conversely, the Right Ventricular Assist Device (RVAD) is emerging rapidly, showcasing increasing adoption rates, thereby indicating a shift in treatment preferences among clinicians.

The growth trends in the South Korea ventricular assist-devices market are influenced by advancements in medical technology, enhancing the effectiveness and safety of these devices. Additionally, an increase in the prevalence of heart-related conditions is driving demand. The RVAD, in particular, is gaining traction due to its potential in treating biventricular failure, showing promise as a viable alternative in critical care settings and making it the fastest-growing segment.

LVAD (Dominant) vs. RVAD (Emerging)

The Left Ventricular Assist Device (LVAD) stands out as the dominant force in the segment, thanks to its established technology and widespread clinical acceptance. LVADs are designed to assist the left ventricle in pumping blood, predominantly for patients awaiting heart transplants or those in advanced heart failure stages. Meanwhile, the Right Ventricular Assist Device (RVAD) is on its way to becoming an emerging alternative, targeted at patients with right-sided heart failure. RVADs enable effective treatment for conditions leading to reduced right ventricular function, thus catering to a specialized subset of patients. As medical professionals continue to seek comprehensive solutions for heart failure, the demand for both devices is expected to grow, albeit at different paces.

### By Type of Flow: Continuous Flow (Largest) vs. Pulsatile Flow (Fastest-Growing)

In the South Korea ventricular assist-devices market, Continuous Flow devices hold a significant share due to their widespread acceptance and proven efficacy in long-term support for heart failure patients. This segment dominates the market, attributed to advancements in technology and increasing clinical evidence supporting their use, often preferred by healthcare professionals.

Conversely, Pulsatile Flow devices are emerging as the fastest-growing segment. Their appeal lies in mimicking natural heartbeats, which enhances patient comfort and outcomes. The growth is driven by innovations targeting specific patient needs, increasing clinical trials, and a rise in heart disease prevalence, creating more opportunities for these devices in the market.

Flow Type: Continuous Flow (Dominant) vs. Pulsatile Flow (Emerging)

Continuous Flow devices are characterized by their ability to provide a steady, uninterrupted flow of blood, making them a reliable choice for many patients requiring long-term heart support. Their robust design and lower risk of thrombosis contribute to their position as the dominant segment in the South Korea ventricular assist-devices market. On the other hand, Pulsatile Flow devices, which create a pulse-like blood flow, represent the emerging technology designed for patients needing more natural rhythm compatibility. This segment is gaining traction due to technological advancements and the increasing focus on personalized patient care, appealing to both clinicians and patients looking for alternatives that enhance quality of life.

### By Design: Implantable Ventricular Assist Device (Largest) vs. Transcutaneous Ventricular Assist Device (Fastest-Growing)

In the South Korea ventricular assist-devices market, the Implantable Ventricular Assist Device segment currently holds the largest share due to its widespread adoption in heart failure treatments. This segment benefits from established manufacturing processes and regulatory approvals, leading to a reliable supply chain. Conversely, the Transcutaneous Ventricular Assist Device segment is emerging rapidly, largely driven by innovations in non-invasive technologies and the growing prevalence of heart diseases, making it increasingly popular among healthcare providers.

The growth trends in this market segment indicate a significant shift towards advanced assist devices that provide effective support with minimal invasiveness. Factors such as technological advancements, increased investments in R&D, and the rising awareness of heart-related conditions are propelling the demand for these devices. Additionally, favorable reimbursement policies and growing healthcare infrastructure in South Korea are facilitating market growth, especially for the fastest-growing Transcutaneous Ventricular Assist Device segment.

Design: Implantable Ventricular Assist Device (Dominant) vs. Transcutaneous Ventricular Assist Device (Emerging)

The Implantable Ventricular Assist Device represents the dominant design in the South Korea ventricular assist-devices market, known for its durability and effectiveness in providing long-term support for patients with severe heart conditions. Its secure placement ensures continuous functionality, making it a preferred choice for clinicians. On the other hand, the Transcutaneous Ventricular Assist Device is gaining attention as an emerging alternative, offering a more user-friendly approach without the need for invasive surgery. This device is particularly appealing to patients seeking less intrusive solutions, and its rapid development is attracting interest in clinical settings, positioning it as a significant player in the market's future.

### By Application: Destination Therapy (Largest) vs. Bridging Therapy (Fastest-Growing)

In the South Korea ventricular assist-devices market, Destination Therapy holds a dominant share compared to Bridging Therapy. This segment primarily appeals to patients with advanced heart failure who require long-term assistance, which has led to a steady market presence as the preferred option for end-stage heart failure treatment. While Bridging Therapy currently occupies a smaller market share, its significance is growing rapidly due to the increased number of patients on waitlists for heart transplants and advancements in device technology.

Current growth trends indicate that Bridging Therapy is becoming the fastest-growing segment within this market. A surge in awareness and clinical acceptance of ventricular assist devices is driving demand. Moreover, innovative technologies and enhancements in device efficiency are expected to foster this segment's expansion, addressing the urgent needs of patients who require temporary support until a permanent solution is available.

Application: Destination Therapy (Dominant) vs. Bridging Therapy (Emerging)

Destination Therapy is characterized by its suitability for patients who are not candidates for heart transplants and rely on ventricular assist devices for prolonged survival and improved quality of life. This segment demonstrates stability in demand, attributed to increasing recognition of device benefits among healthcare professionals. Meanwhile, Bridging Therapy is emerging rapidly, propelled by technological advancements and a growing patient population awaiting transplants. With its temporary nature, Bridging Therapy plays a crucial role in managing cases of acute heart failure, making it an essential consideration for patients and healthcare providers alike.

## Competitive Benchmarking

The [ventricular assist-devices market](https://www.marketresearchfuture.com/reports/ventricular-assist-devices-market-9777) in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of heart failure. Key players such as Abbott (US), Medtronic (US), and Terumo (JP) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott (US) focuses on innovation, particularly in developing next-generation devices that improve patient outcomes. Medtronic (US) emphasizes strategic partnerships and collaborations to expand its product offerings and enhance its technological capabilities. Terumo (JP) is investing in regional expansion, aiming to strengthen its distribution networks and increase accessibility to its devices. Collectively, these strategies contribute to a competitive environment that is increasingly focused on innovation and patient-centric solutions.
In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive technological advancements. This competitive structure fosters an environment where innovation is paramount, compelling smaller players to adapt or collaborate with larger entities to remain relevant.
In October 2025, Abbott (US) announced the launch of its latest ventricular assist device, which incorporates advanced AI algorithms to monitor patient health in real-time. This strategic move is likely to enhance patient management and improve clinical outcomes, positioning Abbott as a leader in the integration of digital health technologies within the market. The introduction of such innovative solutions may redefine patient care protocols and set new benchmarks for device performance.
In September 2025, Medtronic (US) entered into a partnership with a leading South Korean hospital to conduct clinical trials for its new ventricular assist device. This collaboration not only facilitates the collection of valuable clinical data but also strengthens Medtronic's foothold in the region. By aligning with local healthcare providers, Medtronic is likely to enhance its understanding of market needs and accelerate the adoption of its technologies.
In August 2025, Terumo (JP) expanded its manufacturing capabilities in South Korea, investing approximately €20 million in a new facility. This expansion is expected to bolster Terumo's production capacity and improve supply chain efficiency, allowing the company to meet the growing demand for ventricular assist devices. Such investments indicate Terumo's commitment to the South Korean market and its strategy to enhance operational capabilities.
As of November 2025, current trends in the ventricular assist-devices market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to leverage complementary strengths and enhance their product offerings. Looking ahead, competitive differentiation is likely to evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of developing cutting-edge solutions that not only meet regulatory standards but also address the evolving needs of patients and healthcare providers.

## Recent News & Developments

The South Korea Ventricular Assist Devices Market has witnessed significant recent developments, particularly in technology advancements and market expansion. In September 2023, Getinge announced the launch of its latest heart pump technology in South Korea, enhancing treatment options for patients with severe heart conditions. SynCardia, in collaboration with local hospitals, has been increasing the adoption of portable total artificial hearts, which received updated regulatory approval earlier this year.

Additionally, Thoratec's strategic partnerships with South Korea-based research institutions have focused on improving device integration, benefiting patient outcomes.Current affairs reveal that Medtronic plans to increase its footprint in the South Korean market, which is projected to grow due to an increasing aging population and rising cardiology-related health issues. The market valuation for companies like Abiomed and LivaNova has also seen a positive increase due to burgeoning demand for heart failure therapies. Notably, in March 2023, Berlin Heart completed a successful acquisition of a South Korean-based cardiac technology firm to expand its product offerings, evidencing ongoing consolidation in the sector.

The overall market growth illustrates a robust response to the growing healthcare needs within South Korea's cardiovascular landscape.

## Report Scope

| MARKET SIZE 2024 | 39.0(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 42.21(USD Million) |
| MARKET SIZE 2035 | 93.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.22% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), Cleveland Heart (US), ReliantHeart (US), Syncardia (US), Getinge (SE), CardiacAssist (US) |
| Segments Covered | Product Type, Type of Flow, Design, Application |
| Key Market Opportunities | Advancements in miniaturization and battery technology enhance patient mobility in the ventricular assist-devices market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive growth in the ventricular assist-devices market in South Korea. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What is the current valuation of the ventricular assist-devices market in South Korea?**
A: The market valuation was $39.0 Million in 2024.

**Q: What is the projected market size for ventricular assist-devices in South Korea by 2035?**
A: The projected valuation for 2035 is $93.0 Million.

**Q: What is the expected CAGR for the South Korea ventricular assist-devices market during 2025 - 2035?**
A: The expected CAGR during this period is 8.22%.

**Q: Which companies are the key players in the South Korea ventricular assist-devices market?**
A: Key players include Abbott, Medtronic, Boston Scientific, Terumo, Cleveland Heart, ReliantHeart, Syncardia, Getinge, and CardiacAssist.

**Q: What are the main product types in the South Korea ventricular assist-devices market?**
A: The main product types are Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), and Biventricular Assist Device (BIVAD).

**Q: How did the Left Ventricular Assist Device (LVAD) segment perform in 2024?**
A: The LVAD segment was valued at $20.0 Million in 2024 and is projected to reach $48.0 Million.

**Q: What is the market performance of Continuous Flow devices in South Korea?**
A: The Continuous Flow segment was valued at $24.0 Million in 2024 and is expected to grow to $56.0 Million.

**Q: What applications are covered in the South Korea ventricular assist-devices market?**
A: The applications include Destination Therapy and Bridging Therapy.

**Q: What was the valuation of the Destination Therapy segment in 2024?**
A: The Destination Therapy segment was valued at $20.0 Million in 2024 and is projected to reach $46.0 Million.

**Q: What design types are available in the South Korea ventricular assist-devices market?**
A: The design types include Implantable Ventricular Assist Device and Transcutaneous Ventricular Assist Device.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-ventricular-assist-devices-market-51445*